Boston Scientific (BSX) Gross Margin Growth (5y) (2014 - 2026)
Boston Scientific (BSX) Gross Margin Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 142.00 |
| Mar 31, 2026 | 195.00 |
| Dec 31, 2025 | 655.00 |
| Sep 30, 2025 | 261.00 |
| Jun 30, 2025 | 715.00 |
| Mar 31, 2025 | 53.00 |
| Dec 31, 2024 | -287.00 |
| Sep 30, 2024 | -247.00 |
| Jun 30, 2024 | -201.00 |
| Mar 31, 2024 | -205.00 |
| Dec 31, 2023 | -230.00 |
| Sep 30, 2023 | -309.00 |
| Jun 30, 2023 | 31.00 |
| Mar 31, 2023 | -244.00 |
| Dec 31, 2022 | -316.00 |
| Sep 30, 2022 | -222.00 |
| Jun 30, 2022 | -316.00 |
| Mar 31, 2022 | -147.00 |
| Dec 31, 2021 | -283.00 |
| Sep 30, 2021 | -248.00 |